Table 2

Spearman rank correlation coefficients between sCD93 and cardiovascular risk markers

Without T2DWith T2D
ρPρP
Sex−0.0010.9671−0.0450.1882
Age (years)0.0800.00010.166<0.0001
Height (m)−0.0630.0022−0.0540.1163
BMI (kg/m2)−0.0730.0003−0.0420.2199
WHR0.0230.26720.0070.8511
SBP (mmHg)−0.0330.1067−0.0990.0042
SBP (mmHg)*−0.0230.45010.0380.5048
DBP (mmHg)−0.0200.3319−0.0160.6428
DBP (mmHg)*−0.0500.0940−0.0030.9619
LDL cholesterol (mmol/L)0.0420.0422−0.0280.4210
LDL cholesterol (mmol/L)#0.0060.82650.0480.3165
HDL cholesterol (mmol/L)−0.0730.0003−0.0810.0195
HDL cholesterol (mmol/L)#0.0560.0343−0.0190.6872
TG (mmol/L)−0.0510.0131−0.0100.7663
TG (mmol/L)#−0.0980.0002−0.0740.1106
Fasting glucose (mmol/L)−0.0140.51010.0200.5704
C-reactive protein (mmol/L)−0.0140.51010.0200.5704
Current smoking0.0220.2833−0.0040.9027
Lipid-lowering medication−0.0240.24550.0000.9915
Antihypertensive medication−0.0250.21910.0330.3467
Fasting proinsulin (pmol/L)−0.0250.2223−0.0240.4826
Fasting insulin (pmol/L)−0.0780.0001−0.0070.8293
HOMA-B−0.0540.00760.0210.5333
HOMA-IR−0.0800.0001−0.0110.7263
Uric acid (μmol/L)0.0190.35670.0230.5073
Creatinine (μmol/L)0.173<0.00010.237<0.0001
Vitamin D (nmol/L)0.0670.00090.0320.3310
Adiponectin (μg/mL)0.0630.00220.0280.4159
Leptin (ng/mL)−0.0250.21970.0000.9932
IL-5 (pg/mL)0.091<0.00010.0340.3060
FRS0.0220.27190.1030.0019
  • T2D was defined as diagnosis, antidiabetic medication, or fasting glucose level ≥7 mmol/L. FRS, Framingham Risk Score; vitamin D, adjusted for season of blood sampling. Boldface type indicates nominal statistical significance.

  • *Subjects not receiving antihypertensive medication (n = 1,120 and 316 for subjects without diabetes and with T2D, respectively).

  • #Subjects not receiving lipid-lowering medication (n = 1,426 and 462 for subjects without diabetes and with T2D, respectively).